Telix Pharmaceuticals Ltd Earnings Dividend

Telix Pharmaceuticals Ltd’s revenue jumped 755.13% since last year same period to $1.67Mn in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Ltd has generated -74.78% fall in its revenue since last 3-months.

Telix Pharmaceuticals Ltd’s net profit fell -102.52% since last year same period to $-17.5Mn in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Ltd has generated -14530.68% fall in its net profits since last 3-months.

Telix Pharmaceuticals Ltd’s net profit margin jumped 76.32% since last year same period to -1049.33% in the Q4 2019. On a quarterly growth basis, Telix Pharmaceuticals Ltd has generated -57326.66% fall in its net profit margins since last 3-months.

Telix Pharmaceuticals Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.08 - a 155.4% jump from last quarter’s estimates.

Telix Pharmaceuticals Ltd’s earning per share (EPS) estimates for the current year stand at 0.08.

Telix Pharmaceuticals Ltd’s earning per share (EPS) fell -33.33% since last year same period to 0.04 in the Q4 2025. This indicates that the Telix Pharmaceuticals Ltd has generated -33.33% annual rate of fall in its earning per share (EPS) in the last 4 quarters.